1. In a clinical trial to evaluate on-eye performance of TOTAL30® for Astigmatism lenses where n=69; Alcon data on file, 2021. 2. In a clinical trial to evaluate stability of axis orientation of DAILIES TOTAL1® for Astigmatism lenses where n=47; Alcon data on file, 2020. 3. In a clinical trial to assess overall performance of DAILIES TOTAL1® for Astigmatism lenses where n=134 patients; Alcon data on file, 2021.
Aktionsbedingungen
Ausblenden
1. In a clinical trial to evaluate on-eye performance of TOTAL30® for Astigmatism lenses where n=69; Alcon data on file, 2021. 2. In a clinical trial to evaluate stability of axis orientation of DAILIES TOTAL1® for Astigmatism lenses where n=47; Alcon data on file, 2020. 3. In a clinical trial to assess overall performance of DAILIES TOTAL1® for Astigmatism lenses where n=134 patients; Alcon data on file, 2021.
1. In a clinical trial to evaluate on-eye performance of TOTAL30® for Astigmatism lenses where n=69; Alcon data on file, 2021. 2. In a clinical trial to evaluate stability of axis orientation of DAILIES TOTAL1® for Astigmatism lenses where n=47; Alcon data on file, 2020. 3. In a clinical trial to assess overall performance of DAILIES TOTAL1® for Astigmatism lenses where n=134 patients; Alcon data on file, 2021.